About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Minneapolis | 7,824 Studies Near You

Clinical TrialsMinneapolis

Clinical Trials in Minneapolis

Discover 7,824 clinical trials near Minneapolis, Minnesota. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 5621-5640 of 7,824 trials

RecruitingA First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid TumorsThis study investigates the safety and tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of EIK1003 in participants with advanced solid tumors.NCT06253130·Tucson, Arizona and 56 others

Find Trials by Condition in Minneapolis

Breast Cancerin Minneapolis Lung Cancerin Minneapolis Prostate Cancerin Minneapolis Colorectal Cancerin Minneapolis Melanomain Minneapolis Leukemiain Minneapolis Lymphomain Minneapolis Pancreatic Cancerin Minneapolis Ovarian Cancerin Minneapolis Brain Cancerin Minneapolis

Data from ClinicalTrials.govTerms

RecruitingA Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCTThis randomized, open-label, parallel group, two-arm, multi-center assessment will compare IV BCV with IV CDV in adult and pediatric allogeneic HCT recipients with AdV viremia.NCT07387367·Phoenix, Arizona and 80 others

CompletedClesrovimab (MK-1654) in Infants and Children at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease (MK-1654-007)This study aims to evaluate the safety and tolerability of clesrovimab compared to palivizumab as assessed by the proportion of participants experiencing adverse events (AEs).NCT04938830·Long Beach, California and 145 others

CompletedA Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC)Vedolizumab is a medicine that helps to reduce inflammation and pain in the digestive system.NCT04779307·Phoenix, Arizona and 64 others

UnknownA Study of ICP-192 in Patients With Advanced Solid TumorsThis is a multi-center, open-label, phase I/II clinical study to evaluate ICP-192 in patients with advanced solid tumors and FGFR gene alterations.NCT04565275·Tucson, Arizona and 15 others

TerminatedEfficacy And Safety Study Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial SeizuresThis study will determine the safety and efficacy of pregabalin (Lyrica) when administered by itself (without any other anti-epileptic medication) to epilepsy subjects for the…NCT00524030·Northport, Alabama and 72 others

CompletedAllo-HCT MUD for Non-malignant Red Blood Cell (RBC) Disorders: Sickle Cell, Thal, and DBA: Reduced Intensity Conditioning, Co-tx MSCsThe main purpose of this project is to cure patients with high risk Sickle cell disease and other red cell disorders including thalassemia and diamond-blackfan anemia by bone…NCT00957931·Birmingham, Alabama and 1 other

CompletedA Simplification Study of Unboosted Reyataz With Epzicom (ASSURE)This study is designed to compare the efficacy and safety of simplifying therapy from a regimen of atazanavir (ATV) + ritonavir (RTV) + tenofovir/emtricitabine (TDF/FTC) to a…NCT01102972·Hobson City, Alabama and 45 others

CompletedEvaluation of Vitrectomy for Diabetic Macular EdemaThe study is designed as a prospective cohort study to assess changes in visual acuity and retinal thickening and surgical complications in subjects undergoing vitrectomy for…NCT00709319·Irvine, California and 47 others

CompletedOnvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML)The purpose of the phase 1b/2 study is to determine whether Onvansertib given orally daily for 5 consecutive days every 28 days is safe and tolerable in adult patients who have…NCT03303339·Los Angeles, California and 8 others

CompletedImplementation of a Clinical Decision Rule for Treatment of Neonatal Jaundice in the Emergency DepartmentJaundice is a condition caused by elevated levels of bilirubin in the body otherwise known as hyperbilirubinemia.NCT02446951·Minneapolis, Minnesota and 1 other

CompletedStudy of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial CancersPhase 1 trial to study the safety, pharmacokinetics and preliminary efficacy of STRO-002 given intravenously every 3 weeks.NCT03748186·Tucson, Arizona and 26 others

CompletedCombination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath TumorsRATIONALE: Drugs used in chemotherapy, such as doxorubicin, ifosfamide, and etoposide, work in different ways to stop the growth of tumor cells, either by killing the cells or by…NCT00304083·Birmingham, Alabama and 16 others

TerminatedJavelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid TumorsAvelumab in combination with talazoparib will be investigated in patients with locally advanced (primary or recurrent) or metastatic solid tumors, including non-small cell lung…NCT03330405·Fayetteville, Arkansas and 65 others

CompletedAdministration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell TransplantationBackground: * Allogeneic hematopoietic stem cell transplantation (alloHSCT) is a procedure that transplants bone marrow cells (stem cells) from a matching donor into a recipient…NCT01087294·Bethesda, Maryland and 1 other

CompletedMulti-arm Optimization of Stroke ThrombolysisThe primary efficacy objective of the MOST trial is to determine if argatroban (100µg/kg bolus followed by 3µg/kg per minute for 12 hours) or eptifibatide (135µg/kg bolus followed…NCT03735979·Birmingham, Alabama and 60 others

CompletedThe Implementation of a Post-operative Communication App to Improve Pain Control and Opioid UseDigital communication tools are becoming ubiquitous in healthcare, though their impact on patient/provider communication, healthcare utilization, and outcomes remains poorly…NCT06124079·Minneapolis, Minnesota

CompletedAcute Graft-versus-Host Disease Treatment (BMT CTN 0802)The study is a Phase III, randomized double blind, placebo controlled, and trial evaluating the addition of Mycophenolate mofetil (MMF) vs. placebo to systemic corticosteroids as…NCT01002742·Duarte, California and 35 others

CompletedOSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.The purpose of this study is to determine if OSI-774 will improve overall survival when combined with a standard dose of the chemotherapy drug gemcitabine, to individuals with…NCT00040183·Tucson, Arizona and 139 others

Active not recruitingComparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With ChemotherapyThis randomized phase III trial studies lymph node dissection and radiation therapy to see how well it works compared to radiation therapy alone in treating patients with breast…NCT01901094·Daphne, Alabama and 1245 others

PreviousPage 282 of 392Next

Diabetes

in Minneapolis

Heart Diseasein Minneapolis